Table 2.
Outcome of elderly and younger patients with hepatocellular carcinoma undergoing radiofrequency ablation
| Ref. | Age limits (yr) | O/Y |
Survival (%) |
DFS |
||||
| 1 yr | 3 yr | 5 yr | 1 yr | 3 yr | 5 yr | |||
| Tateishi et al[62] | 68 | 159/160 | NA | 76 | NA | NA | NA | NA |
| NA | 79 | NA | NA | NA | NA | |||
| Mirici-Cappa et al[41] | 70 | 159/230 | 90.1 | 53.4 | 29 | NA | NA | NA |
| 89.9 | 52.9 | 35.1 | NA | NA | NA | |||
| Nishikawa et al[31] | 75 | 130/238 | 90 | 64.1 | 44.8 | 66.9 | 21.3 | 19 |
| 97.6 | 83.7 | 64b | 80.5 | 40 | 19.5b | |||
| Takahashi et al[32] | 75 | 107/354 | NA | 82 | 61 | NA | 492 | 562 |
| NA | 80 | 63 | NA | 492 | 562 | |||
| Kao et al[33] | 65 | 158/100 | NA | NA | 81.3 | NA | NA | NA |
| NA | NA | 65.4 | NA | NA | NA | |||
| Hiraoka et al[63] | 75 | 63/143 | 93 | 83 | 501 | NA | NA | NA |
| 93 | 78 | 58 | NA | NA | NA | |||
Data on younger patients are reported in italics. Only articles reporting on either survival and disease free survival (DFS) or overall recurrence2 were considered.
b
P = 0.001;
1
Not significant. O/Y: Old/young; NA: Not available.